Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50549

FORM 10-Q

Filing date
09 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
09 May 2011
Reporting date
09 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
06 May 2011
Reporting date
05 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Apr 2011
Reporting date
15 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
29 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2011
Reporting date
01 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Mar 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-50549

AUTO-GENERATED PAPER DOCUMENT

Filing date
29 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50549

DEF 14A

Filing date
18 Mar 2011
Reporting date
05 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Mar 2011
Reporting date
02 Nov 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Mar 2011
Reporting date
02 Nov 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
16 Mar 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

AMENDMENT NUMBER 1 TO SCHEDULE 13D

Filing date
16 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-79588

SCHEDULE 13D

Filing date
16 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-50549

PRE 14A

Filing date
08 Mar 2011
Reporting date
05 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-50549

FORM 10-K

Filing date
08 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .